Final Thoughts The sick-care system waits for you to break
In general, Ali says he typically starts patients on semaglutide unless they have a significant amount of weight to lose
For instance: people with obesity are more likely to develop type 2 diabetes people with obesity are at an increased riskof developing Alzheimers later in life people with type 2 diabetes are also more likely to develop Alzheimers disease Alzheimers disease is associated with insulin resistance in the brain, with some scientists referring to Alzheimers as type 3 diabetes obesity, type 2 diabetes, and Alzheimers all involve inflammation, and GLP-1 agonists have an anti-inflammatory effect studies in animal models of dementiahave shown that GLP-1 agonists can protect rats brains from damage
Its a gentle, evidence-informed path to feeling more like yourself again
GLP-1 patches vs GLP-1 injections The differences between GLP-1 patches and prescription injections become clearer when you compare how they are regulated, how they work, and who they are suitable for
The starting dose is usually low to allow for a smooth transition, and over the course of several weeks, the dosage is increased to reach the maintenance dose that provides the most benefit for weight loss and blood sugar control